Exploring environmental modifiers of LRRK2-associated Parkinson's disease penetrance: An exposomics and metagenomics pilot study on household dust

被引:0
|
作者
Andujar, Begona Talavera [1 ]
Pereira, Sandro L. [1 ]
Busi, Susheel Bhanu [1 ,2 ]
Usnich, Tatiana [3 ]
Borsche, Max [3 ,4 ]
Ertan, Sibel [5 ]
Bauer, Peter [6 ]
Rolfs, Arndt [6 ]
Hezzaz, Soraya [1 ]
Ghelfi, Jenny [1 ]
Brueggemann, Norbert [3 ,4 ]
Antony, Paul [1 ]
Wilmes, Paul [1 ,7 ]
Klein, Christine [3 ]
Gruenewald, Anne [1 ]
Schymanski, Emma L. [1 ]
机构
[1] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, L-4367 Belvaux, Luxembourg
[2] UK Ctr Ecol & Hydrol, Wallingford, Oxon, England
[3] Univ Lubeck, Inst Neurogenet, Lubeck, Germany
[4] Univ Lubeck, Dept Neurol, Lubeck, Germany
[5] Koc Univ, Sch Med, Dept Neurol, Istanbul, Turkiye
[6] CENTOGENE GmbH, Rostock, Germany
[7] Univ Luxembourg, Fac Sci Technol & Med, Dept Life Sci & Med, L-4362 Esch Sur Alzette, Luxembourg
关键词
Indoor environment; Exposomics; Metagenomics; Parkinson's disease; Leucine-rich repeat kinase 2 (LRRK2); Bisphenol S; MASS-SPECTROMETRY; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; PIPECOLIC ACID; IN-VITRO; MANAGEMENT; RELEVANCE; FIPRONIL; BACTERIA;
D O I
10.1016/j.envint.2024.109151
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Pathogenic variants in the Leucine-rich repeat kinase 2 (LRRK2) gene are a primary monogenic cause of Parkinson's disease (PD). However, the likelihood of developing PD with inherited LRRK2 pathogenic variants differs (a phenomenon known as "reduced penetrance"), with factors including age and geographic region, highlighting a potential role for lifestyle and environmental factors in disease onset. To investigate this, household dust samples from four different groups of individuals were analyzed using metabolomics/exposomics and metagenomics approaches: PD+/LRRK2+ (PD patients with pathogenic LRRK2 variants; n = 11), PD-/LRRK2+ (individuals with pathogenic LRRK2 variants but without PD diagnosis; n = 8), iPD (PD of unknown cause; n = 11), and a matched, healthy control group (n = 11). The dust was complemented with metabolomics and lipidomics of matched serum samples, where available. A total of 1,003 chemicals and 163 metagenomic operational taxonomic units (mOTUs) were identified in the dust samples, of which ninety chemicals and ten mOTUs were statistically significant (ANOVA p-value < 0.05). Reduced levels of 2-benzothiazolesulfonic acid (BThSO3) were found in the PD-/LRRK2+ group compared to the PD+/LRRK2+ . Among the significant chemicals tentatively identified in dust, two are hazardous chemical replacements: Bisphenol S (BPS), and perfluorobutane sulfonic acid (PFBuS). Furthermore, various lipids were found altered in serum including different lysophosphatidylethanolamines (LPEs), and lysophosphatidylcholines (LPCs), some with higher levels in the PD+/LRRK2+ group compared to the control group. A cellular study on isogenic neurons generated from a PD+/LRRK2+ patient demonstrated that BPS negatively impacts mitochondrial function, which is implicated in PD pathogenesis. This pilot study demonstrates how non-target metabolomics/exposomics analysis of indoor dust samples complemented with metagenomics can prioritize relevant chemicals that may be potential modifiers of LRRK2 penetrance.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
    Iakov N Rudenko
    Ruth Chia
    Mark R Cookson
    BMC Medicine, 10 (1)
  • [22] Immunomodulatory properties of hempseed oligopeptides in an LRRK2-associated Parkinson's disease animal model
    Torrecillas-Lopez, Maria
    Rivero-Pino, Fernando
    Trigo, Paula
    Toscano-Sanchez, Rocio
    Gonzalez-de la Rosa, Teresa
    Villanueva, Alvaro
    Millan-Linares, M. Carmen
    Montserrat-de la Paz, Sergio
    Claro-Cala, Carmen M.
    FOOD & FUNCTION, 2024, 15 (22) : 11115 - 11128
  • [23] Clinical and Brain Morphological Characteristics of Early LRRK2-associated Parkinson Disease
    Tao, Q.
    Rahayel, S.
    Tremblay, C.
    Vo, A.
    Dagher, A.
    MOVEMENT DISORDERS, 2024, 39 : S470 - S470
  • [24] Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
    Rudenko, Iakov N.
    Chia, Ruth
    Cookson, Mark R.
    BMC MEDICINE, 2012, 10
  • [25] Reduced Content of α-Synuclein in Peripheral Blood Leukocytes of Patients with LRRK2-Associated Parkinson's Disease
    Pchelina, S. N.
    Emelyanov, A. K.
    Yakimovskii, A. F.
    Miller, D. W.
    Shabalina, I. G.
    Drozdova, A. S.
    Schwarzman, A. L.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 150 (06) : 679 - 681
  • [26] Does Uncoupling Protein 2 Expression Qualify as Marker of Disease Status in LRRK2-Associated Parkinson's Disease?
    Gruenewald, Anne
    Arns, Bjoern
    Meier, Britta
    Brockmann, Kathrin
    Tadic, Vera
    Klein, Christine
    ANTIOXIDANTS & REDOX SIGNALING, 2014, 20 (13) : 1955 - 1960
  • [27] Reduced Content of α-Synuclein in Peripheral Blood Leukocytes of Patients with LRRK2-Associated Parkinson’s Disease
    S. N. Pchelina
    A. K. Emelyanov
    A. F. Yakimovskii
    D. W. Miller
    I. G. Shabalina
    A. S. Drozdova
    A. L. Schwarzman
    Bulletin of Experimental Biology and Medicine, 2011, 150 : 679 - 681
  • [28] Differences in Oculometric Measures Between Patients with LRRK2-Associated and Idiopathic Parkinson's disease (PD)
    Djaldetti, R.
    Raveh, E.
    Reiner, J.
    Franken, L.
    Harpaz, E.
    Kreitman, R.
    Ben-Ami, E.
    MOVEMENT DISORDERS, 2024, 39 : S763 - S764
  • [29] Identification and functional characterization of genetic modifier of penetrance in G2019S LRRK2-associated Parkinson's disease through family whole genome sequencing
    Ohnmacht, J.
    Bobbili, D.
    May, P.
    Glaab, E.
    Kaye, J.
    Finkbeiner, S.
    Kruger, R.
    MOVEMENT DISORDERS, 2022, 37 : S582 - S582
  • [30] Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinson's disease
    Weykopf, Beatrice
    Haupt, Simone
    Jungverdorben, Johannes
    Flitsch, Lea Jessica
    Hebisch, Matthias
    Liu, Guang-Hui
    Suzuki, Keiichiro
    Belmonte, Juan Carlos Izpisua
    Peitz, Michael
    Blaess, Sandra
    Till, Andreas
    Bruestle, Oliver
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (04) : 561 - 589